These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 26370624)
1. Autoantibody Profiling of Glioma Serum Samples to Identify Biomarkers Using Human Proteome Arrays. Syed P; Gupta S; Choudhary S; Pandala NG; Atak A; Richharia A; K P M; Zhu H; Epari S; Noronha SB; Moiyadi A; Srivastava S Sci Rep; 2015 Sep; 5():13895. PubMed ID: 26370624 [TBL] [Abstract][Full Text] [Related]
2. Multi-pronged proteomic analysis to study the glioma pathobiology using cerebrospinal fluid samples. Gahoi N; Malhotra D; Moiyadi A; Varma SG; Gandhi MN; Srivastava S Proteomics Clin Appl; 2018 May; 12(3):e1700056. PubMed ID: 28679024 [TBL] [Abstract][Full Text] [Related]
3. Serum Profiling for Identification of Autoantibody Signatures in Diseases Using Protein Microarrays. Gupta S; Manubhai KP; Mukherjee S; Srivastava S Methods Mol Biol; 2017; 1619():303-315. PubMed ID: 28674893 [TBL] [Abstract][Full Text] [Related]
4. Identification of blood protein biomarkers that aid in the clinical assessment of patients with malignant glioma. Xu BJ; An QA; Srinivasa Gowda S; Yan W; Pierce LA; Abel TW; Rush SZ; Cooper MK; Ye F; Shyr Y; Weaver KD; Thompson RC Int J Oncol; 2012 Jun; 40(6):1995-2003. PubMed ID: 22307528 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of autoantibody signatures in meningioma patients using human proteome arrays. Gupta S; Mukherjee S; Syed P; Pandala NG; Choudhary S; Singh VA; Singh N; Zhu H; Epari S; Noronha SB; Moiyadi A; Srivastava S Oncotarget; 2017 Aug; 8(35):58443-58456. PubMed ID: 28938569 [TBL] [Abstract][Full Text] [Related]
6. Investigation of serum proteome alterations in human glioblastoma multiforme. Gollapalli K; Ray S; Srivastava R; Renu D; Singh P; Dhali S; Bajpai Dikshit J; Srikanth R; Moiyadi A; Srivastava S Proteomics; 2012 Aug; 12(14):2378-90. PubMed ID: 22684992 [TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of genome-wide DNA methylation, gene expression and protein expression profiles in molecular subtypes of WHO II-IV gliomas. Wang ZL; Zhang CB; Cai JQ; Li QB; Wang Z; Jiang T J Exp Clin Cancer Res; 2015 Oct; 34():127. PubMed ID: 26502731 [TBL] [Abstract][Full Text] [Related]
8. Serum GFAP autoantibody as an ELISA-detectable glioma marker. Wei P; Zhang W; Yang LS; Zhang HS; Xu XE; Jiang YH; Huang FP; Shi Q Tumour Biol; 2013 Aug; 34(4):2283-92. PubMed ID: 23589055 [TBL] [Abstract][Full Text] [Related]
9. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma. Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475 [TBL] [Abstract][Full Text] [Related]
10. Circulating anti-filamin C autoantibody as a potential serum biomarker for low-grade gliomas. Adachi-Hayama M; Adachi A; Shinozaki N; Matsutani T; Hiwasa T; Takiguchi M; Saeki N; Iwadate Y BMC Cancer; 2014 Jun; 14():452. PubMed ID: 24946857 [TBL] [Abstract][Full Text] [Related]
11. Absence of p53 autoantibodies in sera from glioma patients. Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045 [TBL] [Abstract][Full Text] [Related]
12. Glioma proteomics: status and perspectives. Niclou SP; Fack F; Rajcevic U J Proteomics; 2010 Sep; 73(10):1823-38. PubMed ID: 20332038 [TBL] [Abstract][Full Text] [Related]
13. [OMICS and biomarkers of glial tumors]. Idbaih A Rev Neurol (Paris); 2011 Oct; 167(10):691-8. PubMed ID: 21889780 [TBL] [Abstract][Full Text] [Related]